This inventor holds 3 USPTO granted patents. Top assignees: The Hong Kong University of Science and Technology, Bayer Aktiengesellschaft. Active years: 2006-2008.
Company Filing History:
2 out of 652 
1 out of 12,266 
Years Active: 2006-2008
Title: Ho-Wai Chan: Innovator in Antiparasitic Research
Introduction
Ho-Wai Chan is a distinguished inventor based in Hong Kong, CN. He has made significant contributions to the field of antiparasitic research, holding a total of 3 patents. His work focuses on developing novel derivatives of artemisinin, which are crucial in combating parasitic infections.
Latest Patents
One of Ho-Wai Chan's latest patents involves antiparasitic artemisinin derivatives (endoperoxides). This invention pertains to the use of specific C-10 substituted derivatives of artemisinin, which are effective in treating and preventing diseases caused by parasitic infections. The compounds developed are particularly effective against malaria, neosporosis, and coccidiosis. The patent outlines the processes for preparing these derivatives and the pharmaceutical compositions that incorporate them.
Career Highlights
Throughout his career, Ho-Wai Chan has worked with reputable institutions, including The Hong Kong University of Science and Technology and Bayer Aktiengesellschaft. His research has significantly advanced the understanding and treatment of parasitic diseases.
Collaborations
Ho-Wai Chan has collaborated with notable colleagues such as Richard K Haynes and William Wai-Lun Lam. These partnerships have further enriched his research and innovation in the field.
Conclusion
Ho-Wai Chan's contributions to antiparasitic research through his innovative patents highlight his role as a key figure in the scientific community. His work continues to impact the treatment of parasitic diseases, showcasing the importance of innovation in healthcare.